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Abstract
Background: The efficacy of mindfulness-based interventions to reduce anxiety or improve quality of 
life (QoL) in patients with cardiac pathologies is well established. However, there is scarce information 
on the efficacy, applicability, and safety of these interventions in adult patients with an implantable 
cardioverter-defibrillator (ICD). In this study, we examined their efficacy on QoL, psychological and 
biomedical variables, as well as the applicability and safety of a mindfulness-based intervention in 
patients with an ICD.
Methods: Ninety-six patients with an ICD were randomized into two intervention groups and a control 
group. The interventions involved training in mindfulness-based emotional regulation, either face-to- 
-face or using the “REM Volver a casa” mobile phone application (app).
Results: The sample presented medium-high QoL baseline scores (mean: 68), low anxiety (6.84) and 
depression (3.89), average mindfulness disposition (128), and cardiological parameters similar to other 
ICD populations. After the intervention, no significant differences were found in the variables studied 
between the intervention and control groups. Retention was average (59%), and there were no adverse 
effects due to the intervention.
Conclusions: After training in mindfulness-based emotional regulation (face-to-face or via app), no 
significant differences were found in the QoL or psychological or biomedical variables in patients with 
an ICD. The intervention proved to be safe, with 59% retention. (Cardiol J)
Key words: quality of life, implantable cardioverter-defibrillator, emotional regulation, 
mindfulness, anxiety
Introduction
Stress, anxiety, and depression are some of the 
psychological disorders associated with pathologies 
of the cardiovascular system, affecting cognitive 
performance and quality of life (QoL) [1–3].
Mindfulness is a complementary interven-
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which has demonstrated psychological benefits 
[2, 4–7]. It has also been shown to be effective in 
cardiovascular diseases [4, 8], facilitating greater 
emotional stability [9–12] and improving mood in 
patients with heart disease [3, 8, 13].
The implanted cardioverter-defibrillator (ICD) 
is a first-line treatment in patients who have had 
poorly tolerated ventricular tachyarrhythmias or 
who have had resuscitated cardiac arrest. It also 
plays a fundamental role in the primary prevention 
of sudden cardiac death in patients with heart dis-
ease and risk of developing malignant ventricular 
arrhythmias. After ICD implantation, many of these 
patients suffer not only from the fear of arrhythmias 
and their possible consequences, but also (and es-
pecially) from the shocks that the ICD can deliver 
to treat arrhythmias [14, 15]. 
In patients with heart disease, Younge et al. [1] 
obtained positive results in the physiological 
parameters (exercise capacity and heart rate) as-
sessed after an online mindfulness-based interven-
tion. However, there is scarce information on the 
influence of this type of intervention in patients 
with ICDs. Salmoirago-Blotcher et al. [12, 16, 17] 
conducted mindfulness-based interventions in this 
type of patient. Their results showed a significant 
increase in participants’ levels of mindfulness but 
did not have a significant effect on anxiety symp-
toms. In addition, they did not study the effect on 
QoL or the biomedical variables of the patients.
The main objective of this pilot study was 
to analyze the efficacy, applicability, and safety of 
a mindfulness-based intervention administered 
face-to-face or through an application (app) on QoL, 
psychological, and biomedical variables in a sample 
of patients with an ICD. The secondary objective 
was to describe the baseline characteristics of 
QoL, psychological, and biomedical variables in 
this population.
Methods
Design and study population
A randomized controlled clinical trial was 
conducted with a pre-post design. 
The study population consisted of patients 
with heart disease and an ICD treated in the 
Arrhythmia Unit of the Cardiology Department of 
a Spanish university hospital. In total, 340 patients 
met the inclusion criteria, which were as follows: 
being over 18 years of age; having an ICD that 
had been implanted 3 months ago or more; having 
sufficient knowledge of Spanish; ownership of 
a mobile phone and the ability to use mobile apps; 
and sufficient availability and physical condition to 
attend face-to-face training in emotional regulation.
The exclusion criteria were as follows: being 
over 75 years of age; being on the waiting list for 
a heart transplant or other heart-related surgery; 
being a current mindfulness practitioner or having 
been one during the last 5 years; or having a severe 
mental disorder in an acute period.
The sample size was calculated to detect 
a difference greater than or equal to 10 units in 
the QoL variable, considering an alpha risk of 0.05 
and beta of 0.2, in a bilateral contrast, as well as 
a standard deviation of 20 points and a loss rate of 
20%. The estimated number of patients was 237, to 
be distributed into three groups of 79 patients each.
Patients were recruited by telephone and were 
randomized using the Excel function [=RAND-
BETWEEN (1;3)]. The participants were randomly 
distributed into three groups: two for the inter-
vention (face-to-face group and app group) and 
a non-intervention control group.
Measuring instruments 
 — SF-36 (Short Form): Health-related QoL sur-
vey [18];
 — HADS (Hospital Anxiety and Depression 
Scale): Scale designed to assess the pres-
ence of anxiety or depression in the medical 
patient [19];
 — STAXI (State-Trait Anger Expression Inven-
tory): Questionnaire that assesses the ex-
pression of anger, both as a personality trait 
and with respect to the state at the time of 
measurement [20];
 — FFMQ (Five Facet Mindfulness Question-
naire): This questionnaire explores five factors 
of mindfulness disposition [21].
Variables
The main outcome variable was QoL, as-
sessed by the SF-36 questionnaire. We assessed 
the degree of applicability based on recruitment 
and retention figures, as well as the safety of both 
interventions in terms of adverse effects reported 
by participants. In each session, we asked about the 
possible occurrence of any psychological discom-
fort or the existence and degree of negative ad-
verse effects. Any discomfort, harm, or increase in 
negative psychological symptoms (anxiety, depres-
sion, anger) arising directly from the intervention 
was considered a negative adverse effect [22, 23].
The secondary variables considered were 
anxiety, depression, anger, mindfulness disposi-
tion, and the following biomedical variables: type 
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of baseline heart disease of the patient, func-
tional class (FC), left ventricular ejection fraction 
(LVEF), indication for ICD implantation, time 
since implantation, history of ICD therapies, and 
pharmacological treatment and its changes during 
the intervention period. The information provided 
by the ICD itself was also analyzed: therapies — 
both appropriate and inappropriate, non-sustained 
ventricular tachycardias, mean heart rate, and daily 
activity of the patient. The data provided by the 
ICD were compared by considering the 2 months 
before and the 2 months after the intervention. 
Ninety-two percent of the patients had remote 
ICD monitoring.
The independent variable was participation in 
a mindfulness-based emotional regulation program, 
either in person or through an app.
The study protocol was approved by the hos-
pital’s Clinical Research Ethics Committee.
Trial registration: ClinicalTrials.gov, identi-
fier NCT04235881.
Interventions
Face-to-face group. A face-to-face 8-week 
group training program was conducted, with 
a maximum of 25 participants, based on the mind-
fulness-based stress reduction program designed 
by Kabat-Zinn. It included all the elements of the 
original training program, except that the sessions 
were 2 hours long and the 7-hour silent practice 
day was not carried out. The program was taught 
by 2 accredited mindfulness-based stress reduc-
tion teachers.
App group. The intervention was carried out 
using the “REM Volver a casa” (“REM coming back 
home”) mobile phone application. This applica-
tion was developed to deliver a user-led 8-week 
mindfulness-based emotional regulation training 
program. It was designed by teachers accredited 
in standardized mindfulness program.
Control group. During the face-to-face and 
app training period, no intervention was carried 
out with the participants assigned to the control 
group. Once the post-intervention data collection 
was completed, the patients in the control group 
were offered the mindfulness-based emotional 
regulation program using the “REM coming back 
home” app.
Statistical analysis
In the descriptive analysis, the absolute fre-
quency (n) and relative frequency (%) were cal-
culated for qualitative variables. For quantitative 
variables, the normality of the distributions of 
the variables was tested using the Kolmogorov-
-Smirnov goodness-of-fit test, expressed as median 
and interquartile range (IQR). For the analysis of 
group independence, the Kruskal-Wallis H test 
was used for quantitative variables, and the c2 test 
(chi-square with Fisher’s exact test) was used for 
categorical variables.
The efficacy of the intervention was analyzed 
by comparisons between the three study groups. 
An additional analysis was also chosen, pooling the 
two intervention groups and comparing the overall 
group with the control group. The tool used was 
the Mann-Whitney U test.
For the analysis of drop-out and retention of 
the study participants, we used the c2 test (chi-
-square) for categorical variables and the Mann-
-Whitney U test for quantitative variables.
For all tests, the p-values for all results were 
bilateral; a value of < 0.05 indicated statistical 
significance. 
Statistical analyses were performed using 
SPSS, version 20 (IBM Corp., United States).
Results
A total of 251 patients were randomized, of 
whom 96 started the study and 57 completed it 
(Fig. 1).
Baseline characteristics
The sample, 74% male, had a median age of 
60 years (49–67). The median age was higher in 
the face-to-face group (65 [53–71]) than in the 
app group (59 [47–64; p = 0.013]) or the control 
group (56 [46–67; p = 0.052]), and it was higher 
in men (61 [51–68]) than in women (53 [46–61; 
p = 044]). Almost half (49%) of the participants in 
the app group had a university education, compared 
to just over a third (36%) in the face-to-face group.
Regarding baseline heart disease, half (52%) 
of the participants had ischemic heart disease 
with previous myocardial infarction; slightly fewer 
than half (41%) had non-ischemic cardiomyopathy, 
mainly dilated, and a minority (7%) had primary 
electrical disease. Median LVEF was 31% (25–50). 
45.8% were in FC II and 14.6% were in FC III. 
Fewer patients in FC III were found in the face- 
-to-face group (2.8%) than in the app (17.1%) and 
control (31.6%) groups. In slightly more than half 
(56%) of participants, the implant was performed 
as primary prevention; in 44% it was performed 
as secondary prevention. The mean time from 
implantation to completion of the study was 2.9 ± 
± 2.14 years.
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Twenty-three percent of the study participants 
had shocks in the period between implantation and 
the completion of the study (mean time of 2 years).
Quality of life scores were medium-high 
(73 [65–90]), low anxiety (6 [4–9]) and depression 
(3 [1–5.5]), and average in mindfulness disposition 
(128 [118–139]).
Except for the age variable and FC, there were 
no statistically significant differences between the 
groups (Table 1).
Results of the intervention
No significant differences were found between 
the intervention and control groups for QoL, anxiety, 
anger, or depression scores or biomedical variables 
(appropriate or inappropriate therapies, non-sus-
tained ventricular tachycardias, mean heart rate, or 
mean daily activity). However, for the general health 
dimension of the QoL variable, the difference cor-
responding to the contrast between the face-to-face 
group and the control group was significant (Table 2).
In the comparison between the two interven-
tion groups grouped together (face-to-face and 
app) and the control group, statistical significance 
was not reached in any of the variables (Table 3). 
The comparison test between secondary studies 
(n = 10) vs. university studies (n = 24) only reported 
statistically significant differences (p = 0.040) 
in the mental health dimension of the QoL 
variable. Due to the low number of patients, no 
comparisons were made with other educational 
levels.
Applicability
Recruitment reached almost 74% of potential 
participants. After randomization and allocation of 
participants to the study groups, the drop-out rate 
was 62%. Subsequently, during the intervention, 
the drop-out rate was 40%. Retention was average 
in the face-to-face (47%) and app (56%) groups, 
with no significant difference between them 
(p = 0.497). In the control group, retention was 
high (89%), with a significant difference compared 
to the face-to-face (p = 0.003) and app (p = 0.017) 
groups. Female retention (80%) was higher than 
male retention (52%; p = 0.018). Apart from group 
type and sex, no other variables related to drop-out 
or retention in the study were identified.
Safety
During the sessions, participants in the face- 
-to-face group reported no negative adverse effects, 
such as anxiety, stress, low mood, or other psycho-
logical distress. Nor did the app group participants 
Registration 
Patients for recruitment (n = 340)
Refused to participate (n = 89)
Did not have time
Not interested
Assignment
Face-to-face group (n = 84)
Did not accept group (n = 48)
Intervention (n = 36)
App group (n = 83)
Did not accept group (n = 42)
Intervention (n = 41)
Control group (n = 84)
Did not accept group (n = 65)









Analyzed (n = 17) Analyzed (n = 23) Analyzed (n = 17)
Randomized (n = 251)
Figure 1. Study flowchart.
4 www.cardiologyjournal.org
Cardiology Journal 20XX, Vol. XX, No. X
Table 1. Study variables.














Age [years] 65 (53–71) 59 (47–64) 56 (46–67) (2) = 7.170 0.028*
Sex: c2 = 0.464 0.869
Female 9 (25.0%) 12 (29.3%) 4 (21.1%)
Male 27 (75.0%) 29 (70.7%) 15 (78.9%)
Educational level: c2 = 3.672 > 741
None 04 (11.1%) 04 (9.7%) 2 (10.5%)
Primary 08 (22.2%) 07 (17.1%) 4 (21.1%)
Secondary 11 (30.6%) 10 (24.4%) 8 (42.1%)
University 13 (36.1%) 20 (48.8%) 5 (26.3%)
Cardiology/implantable cardioverter-defibrillator
Functional class: c2 = 10.118 0.034*
I 15 (41.7%) 15 (36.6%) 8 (42.1%)
II 20 (55.5%) 19 (46.3%) 5 (26.3%)
III 1 (2.8%) 7 (17.1%) 6 (31.6%)
IV 0 (0.0%) 0 (0.0%) 0 (0.0%)
Prevention:  c2 = 4.285 > 127
Primary 25 (69.4%) 19 (46.3%) 10 (52.6%)
Secondary 11 (30.6%) 22 (53.7%) 9 (47.4%)
Pathology: c2 = 1.046 0.927
No heart disease 2 (5.5%) 4 (9.8%) 1 (5.4%)
Ischemic 20 (55.6%) 21 (51.2%) 9 (47.3%)
Non-ischemic 14 (38.9%) 16 (39.0%) 9 (47.3%)
Shocks: c2 = 1.728 0.440
No 30 (83.3%) 31 (75.6%) 13 (68.4%)
Yes 6 (16.7%) 10 (24.4%) 6 (31.6%)
Implant years 3.0 (2.0–3.4) 3.0 (2.5–3.9) 3.0 (2.4–3.6) 0.368
LVEF 33 (28–49)  34 (30–50) 28 (25–50) (2) = 2.834 0.242
Mean heart rate 65.5 (62.5–70) 65.0 (65–70) 65.0 (60–70) (2) = 0.495 0.781
NSVT 0 (0–1) 0 (0–1) 0 (0–0) (2) = 0.677 0.713
Daily activity [h] 3 (2–3.4) 3 (2.5–3.9) 3 (2.4–3.6) (2) = 0.641 0.726
Quality of life
Physical functioning 70.0 (60.0–85.0) 85.0 (65–95) 80.0 (60–95) (2) = 3.427 0.180
Role physical 100 (62.5–100) 100 (50–100) 100 (25–100) (2) = 0.209 0.901
Bodily pain 72.0 (60.5–84.0) 72 (62–90) 74 (51–84) (2) = 0.513 0.774
General health 48.5 (31.0–59.5) 52.0 (37–72) 52.0 (40–77) (2) = 1.703 0.427
Vitality 52.5 (47.5–75.0) 65.0 (55–80) 55.0 (30–75) (2) = 3.536 0.171
Social functioning 87.5 (62.5–100) 87.5 (62.5–100) 75.0 (50–100) (2) = 1.383 0.501
Role emotional 100.0 (0.0–100) 100 (33.3–100) 100 (0–100) (2) = 1.528 0.466
Mental health 74.0 (58.0–84.0) 76.0 (60–88) 64 (48–84) (2) = 1.441 0.487
Physical component summary 75.65 (57.3–87) 82.3 (66.7–89) 78 (45.3–93) (2) = 0.738 0.691
Mental component summary 80.2 (47.6–93.3) 86.5 (62.6–96) 71.1 (39.5–94) (2) = 1.516 0.469
Overall 51.0 (45.5–65.5) 58.5 (46.0–76) 51.0 (35–73.5) (2) = 2.345 0.310
Æ
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indicate psychological distress in their individual 
practices.
Discussion
To our knowledge, this study is the first ran-
domized clinical trial to study the applicability 
and efficacy of 2 mindfulness-based interventions: 
face-to-face and app-based, in adult patients fitted 
with an ICD, to improve QoL, psychological, and 
biological variables.
As with other studies [24, 25], the baseline 
characteristics of our sample showed medium-high 
values in most of the scales of the QoL variable. 
The cardiological biomedical characteristics of 
the population in this study were also similar to 
those found in other ICD patient populations, such 
as those of the Spanish Society of Cardiology’s 
ICD Registry [26]. These data, together with the 
absence of symptoms of anxiety, depression, and 
anger, suggest that having an ICD, not recently 
implanted, does not entail lower QoL. In addition, 
the data would justify the absence of significant 
changes in the scores obtained after the interven-
tion [27].
Numerous studies have shown that ICD shocks 
are the main determinant of poorer QoL, increased 
anxiety, and psychological disturbances [28–30]; in 
our study, only 23% of the included patients had 
experienced a previous ICD shock. In addition, 
some studies have shown that in the early post-ICD 
implantation period, there is a greater deteriora-
tion in QoL and emotional impairment [31]. In our 
sample, the proportion of patients who had been 
implanted less than a year ago was small (28%). 
The small sample size probably explains why 
some trends towards favorable changes in the in-
tervention groups compared to the control group 
did not reach statistical significance, except for 
the improvement in the general health dimension 
of the QoL variable in the face-to-face group com-
pared to the control group.
Educational level does not seem to affect the 
results of mindfulness training. However, a higher 
educational level (university) could have a favora-
ble effect on mental health, an effect that was found 
in the comparison between the levels of secondary 
and university studies.
In patients with cardiovascular disease, sever-
al studies, reviews, and meta-analyses have shown 
that this type of intervention has a moderate effect 
on outcomes relating to psychological variables 
and unclear effects on biological variables [32]. 
A recent systematic review and meta-analysis [33] 
showed an improvement in psychological variables 
as well as in systolic, although not diastolic, blood 
pressure. However, the QoL of patients was not 
analyzed in this review and patients with ICDs 
were not included. On the other hand, the effect 
obtained by Salmoirago-Blotcher et al. [16] on anxi-
ety symptoms did not reach statistical significance 
in the overall group; it was only reached if patients 
who performed all sessions were considered.
Dash et al. [34], in a pilot study on the effect of 
meditation in 25 heart failure patients with ICDs, 
demonstrated a reduction in episodes of atrial 
fibrillation and sustained ventricular tachycardia. 
However, we used a rough analysis of these epi-
sodes, not adjusted for the number of episodes per 
patient, which is a major methodological limitation.
Table 1 (cont.). Study variables.














Anxiety 6.0 (4.0–10.0) 6.0 (3.0–8.0) 7.0 (5.0–10.0) (2) = 1.788 0.409
Depression 3.5 (2.0–5.0) 2.0 (1.0–5.0) 3.0 (1.0–6.0) (2) = 0.837 0.658
Anger (state)  15.0 (15–19) 15.0 (15–16) 15.0 (15–17) (2) = 1.068 0.586
Anger (trait)  18.0 (14–22) 17.0 (15–21) 19.0 (15–21) (2) = 0.378 0.828
Anger Expression Index 29.0 (21–36) 28.0 (19–33) 25.0 (19–35) (2) = 0.551 0.759
Mindfulness total 128 (118–140) 127 (119–136) 124 (109–141) (2) = 0.760 0.684
Data are shown as median (interquartile range) or number (%). Test: Kruskal-Wallis H, unless specified. c2 (chi-square); *P value for  
alpha = 0.05; LVEF — left ventricular ejection fraction; NSVT — non-sustained ventricular tachycardia
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Regarding the lack of effect of the intervention 
on biomedical variables, in the study by Toise et 
al. [15], the number of device therapies was lower 
in the intervention group than in the control group 
(2014 study). We believe that the absence of differ-
ences in our study is mainly due to a short pre- and 
post-intervention analysis time window and better 
scheduling of screening and therapies in ICDs.   
Despite the high recruitment rate (74%), 
which is much higher than that reported in other 
studies (Salmoirago-Blotcher et al. [16] — 13%; 
Frizelle et al. [35] — 28%), the sample was greatly 
reduced due to the high number of dropouts. The 
patients explained the dropouts as being due to dif-
ficulties in participating or a preference for a group 
other than the assigned group. The dropouts from 
the control group (77%) correspond to patients 
who did not want to be part of this group or did 
not want to wait a long time to receive training 
through the application for mobile terminals. It is 
noteworthy that only 3% of the patients with FC III 
were in the face-to-face group, probably because 
the greater physical demands of this format led 
them to refuse to participate. On the other hand, 
some patients assigned to the mobile phone app 
group gave technical difficulties with the use of the 
mobile phone as a reason for dropping out.
The mean retention rate (59%) was far from 
that reported by Salmoirago-Blotcher et al. [16] 
(93%) or that of the systematic review conducted 
by Scott-Sheldon [33] (81%). The lack of explicit 
follow-up during the intervention may have been 
the reason for failure to achieve higher retention.
Clinical implications
The neutral results of this pilot study, in terms 
of the effects of the intervention in an unselected 
population of patients fitted with ICDs, suggest 
that it would probably be more efficient to use it in 
patients with higher levels of anxiety, depression, 
Table 3. Pre-post differences in each group and contrast between joined intervention group and control group.
Participants with intervention  
vs. control group






Mean heart rate 0.0 (–5.0 to 0.0) 0.00 (0.00 to 0.00) 334.0 0.901
NSVT 0.0 (–1.0 to 0.0) 0.00 (0.00 to 0.00) 322.5 0.716
Daily activity 0.2 (0.0 to 0.9) 0.30 (0.00 to 0.50) 297.0 0.451
Quality of life
Physical functioning 0.0 (–5.0 to 5.0) 5.0 (–5.0 to 20.0) 262.0 0.166
Role physical 0.0 (0.0 to 0.0) 0.0 (0.0 to 0.0) 323.5 0.727
Bodily pain 0.0 (–3.0 to 11.0) 0.0 (–6.0 to 6.0) 292.5 0.395
General health 5.0 (0.0 to 13.5) 0.0 (–5.0 to 5.0) 232.5 0.058
Vitality 5.0 (–5.0 to 12.5) 10.0 (0.0 to 10.0) 304.5 0.532
Social functioning 0.0 (0.0 to 12.5) 0.0 (0.0 to 25.0) 271.0 0.197
Role emotional 0.0 (0.0 to 33.3) 0.0 (0.0 to 0.0) 307.0 0.492
Mental health 4.0 (0.0 to 12.0) 4.0 (–4.0 to 8.0) 314.0 0.647
Physical component summary 1.0 (–3.4 to 8.7) 0.0 (–1.6 to 11.0) 297.5 0.458
Mental component summary 2.7 (0.0 to 15.85 1.3 (–1.4 to 12.7 305.5 0.546
Overall 2.5 (–1.25 to 13.8) 5.0 (0.0 to 6.0) 312.0 0.624
Psychological variables
Anxiety –0.5 (–2.0 to 0.0) –2.0 (–2.0 to 0.0) 293.5 0.411
Depression 0.0 (–1.5 to 1.0) –1.0 (–2.0 to 0.0) 255.5 0.133
Anger (state) 0.0 (–1.0 to 0.0) 0.0 (–1.0 to 0.0) 334.5 0.917
Anger (trait) –1.0 (–4.0 to 2.0) –1.0 (–2.0 to 0.0) 335.0 0.930
Anger Expression Index –1.0 (–6.0 to 5.0) –2.0 (–4.0 to 1.0) 316.0 0.675
Mindfulness total 4.0 (-4.0 to 10.0) 5.0 (-4.0 to 12.0) 294.0 0.637
Data are shown as median (interquartile range). Test: Mann-Whitney U; NSVT — non-sustained ventricular tachycardia
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or stress and poorer QoL, ideally after the onset 
of ICD shocks.
We did not obtain results that would lead us 
to think about a better response to training in 
patients who have suffered ICD discharges. Only 
8 patients with shock underwent mindfulness 
training. Hence, it was not possible to obtain con-
clusive results regarding training when comparing 
8 patients with shocks vs. 32 without shocks. No 
statistically significant differences were found in 
the analysis (U Mann-Whitney).
The low retention rate observed in the study 
and the current low incidence of shocks in patients 
with ICDs suggest that future studies in this field 
should be designed as multi-center studies in order 
to achieve adequate sample sizes.
Finally, it is demonstrated that the app interven-
tion is feasible and can be used for this type of training.
Limitations of the study
The main limitation of our study was the low 
number of patients in each group, which meant we 
were unable to draw conclusive results. Other studies 
with a much smaller size, such as the 45 participants 
in the study by Salmoirago-Blotcher et al. [16], found 
significant results for the anxiety variable.
The high dropout rate in both intervention 
branches could be an expression of the fact that pa-
tients with ICDs do not find this type of tool useful.
Another limitation was that patients with ICD 
shocks (the main predictor of QoL impairment and 
anxiety in these patients) or with recent implanta-
tion were under-represented.
Finally, a lack of information on attendance at 
the sessions, or on the use of the app, means that 
we cannot provide data on treatment compliance.
Conclusions
After patients with an ICD completed an 8-week 
mindfulness training program, either face-to-face or 
through an app, no significant differences were found 
in QoL, psychological, or biomedical variables.
The intervention program, both face-to-face 
and via app, was well accepted by participants, 
with a retention rate of 59% and no adverse effects 
reported.
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